Emerging Resistance in Clinically Important Gram-Positive Cocci

Western Journal of Medicine

Volumn 164, Issue 1, 1996, Pages 28-32

  Thornsberry, Clyde ^a  

^a MRL Pharmaceutical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROCOCCUS; GRAM POSITIVE COCCI; HUMAN; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE COCCI; HUMANS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029694065     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Horan T, Culver D, Jarvis W, et al: Pathogens causing nosocomial infections - Preliminary data from the National Nosocomial Infections Surveillance System. Antimicrob Newslett 1988; 5:65
2. Jevons MP: 'Celbenin'-resistant staphylococci. Br Med J 1961; 2:124-125
3. Parker MT: Methicillin-Resistant Staphylococci. Proceedings of the International Conference of Nosocomial Infections. Chicago, Ill, American Hospital Assoc, 1970, pp 112-115
4. Kirby WMM: Extraction of a highly potent penicillin inactivator from penicillin-resistant staphylococci. Science 1944; 99:452
5. Haley RW, Hightower AW, Khabbaz RF, et al: The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals - Possible role of the house staff-patient transfer circuit. Ann Intern Med 1982; 97:297-308
6. Tomasz A: Penicillin-binding proteins and the antibacterial effectiveness of β-lactam antibiotics. Rev Infect Dis 1986; 8(suppl):S260-278
7. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC: Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37:2311-2317
8. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests - NCCLS document M2-A5, approved standard edition 5. Villanova, Penn, National Committee for Clinical Laboratory Standards, 1994
9. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - NC-CLS document M7-A3, approved standard edition 3. Villanova, Penn, National Committee for Clinical Laboratory Standards, 1994
10. Woodford N, Johnson AP, Morrison D, Speller DCE: Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8:585-615
11. Hansman D. Bullen MM: A resistant pneumococcus (Letter). Lancet 1967; 2:264-265
12. Paredes A, Taber LH, Yow MD, et al: Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics 1976; 58:378-381
13. Spika JS, Facklam RR, Plikaytis BD, et al: Antimicrobial resistance of Streptococcus pneumoniae in the United States 1979-1987. J Infect Dis 1991; 163:1273-1278
14. Jorgensen JH, Doem GV, Maher LA, Howell AW, Redding JS: Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34:2075-2080
15. Thornsberry C, Brown SD, Yee YC, Bouchillon SK, Marier K, Rich T: Increasing penicillin resistance in Streptococcus pneumoniae in the US. Infect Med 1993; (Suppl):15-24
16. Swenson JM, Hill BC, Thornsberry C: Screening pneumococci for penicillin resistance. J Clin Microbiol 1986; 24:749-752
17. Thornsberry C, Burton PH, Vanderhoof BH: Increasing resistance to third-generation cephalosporins (TGC) in Streptococcus pneumoniae - A 1995 Surveillance Study in the United States. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Late-Breaker Abstract #LB-24, 1995
18. S) S pneumoniae. Am Soc Microbiol 1993; Abstract #A39